These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 25000468)
41. Identification of DKC1 gene mutations in Japanese patients with X-linked dyskeratosis congenita. Kanegane H; Kasahara Y; Okamura J; Hongo T; Tanaka R; Nomura K; Kojima S; Miyawaki T Br J Haematol; 2005 May; 129(3):432-4. PubMed ID: 15842668 [TBL] [Abstract][Full Text] [Related]
42. Heart failure after allogeneic hematopoietic stem cell transplantation. Mo XD; Xu LP; Liu DH; Zhang XH; Chen H; Chen YH; Han W; Wang Y; Wang FR; Wang JZ; Zhao T; Yan CH; Sun YQ; Liu KY; Huang XJ Int J Cardiol; 2013 Sep; 167(6):2502-6. PubMed ID: 22727962 [TBL] [Abstract][Full Text] [Related]
43. Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post transplant recovery predict survival. Dean R; Masci P; Pohlman B; Andresen S; Serafino S; Sobecks R; Kuczkowski E; Curtis J; Maciejewski J; Rybicki L; Kalaycio M; Hsi E; Theil K; Bolwell BJ Bone Marrow Transplant; 2005 Dec; 36(12):1049-52. PubMed ID: 16247431 [TBL] [Abstract][Full Text] [Related]
44. Dyskeratosis congenita. Report of a case with literature review. Auluck A Med Oral Patol Oral Cir Bucal; 2007 Sep; 12(5):E369-73. PubMed ID: 17767101 [TBL] [Abstract][Full Text] [Related]
45. [Recurrent pulmonary infection and oral mucosal ulcer]. Kuang FM; Tang LL; Zhang H; Xie M; Yang MH; Yang LC; Yu Y; Cao LZ Zhongguo Dang Dai Er Ke Za Zhi; 2017 Apr; 19(4):452-457. PubMed ID: 28407835 [TBL] [Abstract][Full Text] [Related]
46. Hepatic Angiosarcoma with Dyskeratosis Congenita. Horiguchi N; Kakizaki S; Iizuka K; Hagiwara S; Ohyama T; Yamazaki Y; Shibusawa N; Sato K; Kusano M; Nakazato Y; Yamada M Intern Med; 2015; 54(22):2867-72. PubMed ID: 26568000 [TBL] [Abstract][Full Text] [Related]
47. Correction of bone marrow failure in dyskeratosis congenita by bone marrow transplantation. Ghavamzadeh A; Alimoghadam K; Nasseri P; Jahani M; Khodabandeh A; Ghahremani G Bone Marrow Transplant; 1999 Feb; 23(3):299-301. PubMed ID: 10084264 [TBL] [Abstract][Full Text] [Related]
48. Identification of a novel mutation in DKC1 in dyskeratosis congenita. Kurnikova M; Shagina I; Khachatryan L; Schagina O; Maschan M; Shagin D Pediatr Blood Cancer; 2009 Jan; 52(1):135-7. PubMed ID: 18802941 [TBL] [Abstract][Full Text] [Related]
49. Reconsidering the indication of haematopoietic stem cell transplantation for dyskeratosis congenita. Kojima S; Ehlert K Br J Haematol; 2018 Oct; 183(1):11-12. PubMed ID: 29978455 [No Abstract] [Full Text] [Related]
50. [Genetic analysis of a patient with dyskeratosis congenita]. Yoshimoto T; Yanabe Y; Mizukami T; Ishibashi F; Adachi N; Takaki K; Nunoi H Rinsho Ketsueki; 2000 Jun; 41(6):524-9. PubMed ID: 10921354 [TBL] [Abstract][Full Text] [Related]
51. The diagnosis and treatment of dyskeratosis congenita: a review. Fernández García MS; Teruya-Feldstein J J Blood Med; 2014; 5():157-67. PubMed ID: 25170286 [TBL] [Abstract][Full Text] [Related]
52. Oral and dental phenotype of dyskeratosis congenita. Atkinson JC; Harvey KE; Domingo DL; Trujillo MI; Guadagnini JP; Gollins S; Giri N; Hart TC; Alter BP Oral Dis; 2008 Jul; 14(5):419-27. PubMed ID: 18938267 [TBL] [Abstract][Full Text] [Related]